RAYVEN Trademark

Trademark Overview


On Wednesday, January 27, 2016, a trademark application was filed for RAYVEN with the United States Patent and Trademark Office. The USPTO has given the RAYVEN trademark a serial number of 86888018. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 23, 2019. This trademark is owned by Actavis, Inc.. The RAYVEN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceutica...

Contraceptive device, namely, an intrauterine device
rayven

General Information


Serial Number86888018
Word MarkRAYVEN
Filing DateWednesday, January 27, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting the urogenital organs; Pharmaceuticals and medicines affecting the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Goods and ServicesContraceptive device, namely, an intrauterine device

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 1, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameACTAVIS HOLDCO US, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054

Party NameALLERGAN FINANCE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressPARSIPPANY, NJ 07054

Party NameActavis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameActavis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Monday, September 23, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 23, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 26, 2019EXTENSION 5 GRANTED
Thursday, February 21, 2019EXTENSION 5 FILED
Tuesday, February 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 21, 2019TEAS EXTENSION RECEIVED
Friday, August 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 15, 2018EXTENSION 4 GRANTED
Wednesday, August 15, 2018EXTENSION 4 FILED
Wednesday, August 15, 2018TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2018EXTENSION 3 GRANTED
Friday, February 16, 2018EXTENSION 3 FILED
Friday, February 16, 2018TEAS EXTENSION RECEIVED
Friday, August 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2017EXTENSION 2 GRANTED
Wednesday, August 23, 2017EXTENSION 2 FILED
Wednesday, August 23, 2017TEAS EXTENSION RECEIVED
Wednesday, July 5, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 12, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, February 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2017EXTENSION 1 GRANTED
Thursday, February 23, 2017EXTENSION 1 FILED
Thursday, February 23, 2017TEAS EXTENSION RECEIVED
Tuesday, August 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 14, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 14, 2016NON-FINAL ACTION E-MAILED
Saturday, May 14, 2016NON-FINAL ACTION WRITTEN
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Monday, February 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 30, 2016NEW APPLICATION ENTERED IN TRAM